Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Pichon

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|October 1, 1981
Thyroid hormone receptors in human breast cancerM A Cerbon, M F Pichon, E Milgrom
Anticancer Research|June 12, 1999
Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumorsM F Pichon, G Coquin, C Fauveau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Prognostic value of progesterone receptors in primary breast cancerM F Pichon, C Pallud, M Brunet, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Estradiol and progesterone receptors content and response to norethisterone treatment in advanced breast cancerB Clavel, M F Pichon, C Pallud, et al.
Cancer Research|September 1, 1980
Relationship of presence of progesterone receptors to prognosis in early breast cancerM F Pichon, C Pallud, M Brunet, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1980
Estrogen receptors in human pituitary adenomasM F Pichon, D Bression, F Peillon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic value of progesterone receptor after long-term follow-up in primary breast cancerM F Pichon, C Pallud, K Hacene, et al.
Pathologie-Biologie|January 6, 2001
[1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center]A P Pecking, C Mechelany-Corone, M F Pichon
Molecular and Cellular Endocrinology|March 1, 1988
Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell lineN Guilbaud, M F Pichon, J C Faye, et al.
Anticancer Research|May 16, 2000
Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patientsM F Pichon, G Moulin, C Pallud, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|October 1, 1981
Thyroid hormone receptors in human breast cancerM A Cerbon, M F Pichon, E Milgrom
Anticancer Research|June 12, 1999
Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumorsM F Pichon, G Coquin, C Fauveau, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
Prognostic value of progesterone receptors in primary breast cancerM F Pichon, C Pallud, M Brunet, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Estradiol and progesterone receptors content and response to norethisterone treatment in advanced breast cancerB Clavel, M F Pichon, C Pallud, et al.
Cancer Research|September 1, 1980
Relationship of presence of progesterone receptors to prognosis in early breast cancerM F Pichon, C Pallud, M Brunet, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1980
Estrogen receptors in human pituitary adenomasM F Pichon, D Bression, F Peillon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prognostic value of progesterone receptor after long-term follow-up in primary breast cancerM F Pichon, C Pallud, K Hacene, et al.
Pathologie-Biologie|January 6, 2001
[1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center]A P Pecking, C Mechelany-Corone, M F Pichon
Molecular and Cellular Endocrinology|March 1, 1988
Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell lineN Guilbaud, M F Pichon, J C Faye, et al.
Anticancer Research|May 16, 2000
Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patientsM F Pichon, G Moulin, C Pallud, et al.
Pageof 5